Tag: for

Further hope for BCG vaccine in stemming type 1 diabetes

At the recent 2021 Annual Scientific Sessions of the American Diabetes Association, researchers from Massachusetts General Hospital (MGH) presented positive updates on their trials of the bacillus Calmette-Guérin (BCG) vaccine to safely and significantly lower blood sugars. In type 1 diabetes, an autoimmune disease which currently has no cure, T cells attack the pancreas and

FDA authorizes Roche drug for severely ill COVID-19 patients

COVID vaccines and heart inflammation in young adults a ‘likely’ link: CDC panel Fox News medical contributor Dr. Janette Nesheiwat argues the condition is extremely rare and says vaccine benefits outweigh any potential side effects. The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving

ED visits for leiomyomas increased from 2006 to 2017

From 2006 to 2017, there was an increase in the number of emergency department visits for leiomyomas, but the admission rate for these visits decreased, according to a study published in the May issue of Obstetrics & Gynecology. Chelsea N. Fortin, M.D., from the University of Michigan in Ann Arbor, and colleagues described trends in

FETO beneficial for severe left congenital diaphragmatic hernia

(HealthDay)—Fetoscopic endoluminal tracheal occlusion (FETO) offers significant benefit for singleton fetuses with severe, but not moderate, isolated congenital diaphragmatic hernia on the left side, according to two studies published online June 8 in the New England Journal of Medicine to coincide with the International Society for Prenatal Diagnosis 25th International Conference on Prenatal Diagnosis and

No cause for alarm about graduate students’ mental health

Talk of a graduate student mental health crisis is abundant in academic and popular media, but a University of Otago study has found no evidence of one in New Zealand. The study, published in Frontiers in Psychology, used data from the Graduate Longitudinal Study New Zealand to compare the mental wellbeing of students who did,

Experts call for better design of early drug trials for Alzheimer’s and related dementias

An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology, the medical journal

Anna Faris Blamed Herself for Son Jack's Premature Birth

Anna Faris opened up about how the nerve-wracking experience of delivering her son inspired her to start raising awareness about premature births. Celeb Parents’ Potty Training Confessions “I was 35 — a geriatric pregnancy, as my OB-GYN delicately put it — and I had been having what I thought was a pretty amazing pregnancy,” Faris,

Latest remedy for eczema – rub bacteria on to your skin!

Latest remedy for eczema — rub bacteria on to your skin! Healthy strain of skin bacteria can effectively treat flare-ups in people with the most common form of eczema, studies suggest Scientists have developed an unlikely treatment for the dry skin condition eczema — a cream that is packed with human skin bacteria. Studies suggest

ATA issues guidelines for managing anaplastic thyroid cancer

(HealthDay)—In new guidelines issued by the American Thyroid Association and published in the March issue of Thyroid, recommendations are presented for the diagnosis, evaluation, and treatment of anaplastic thyroid cancer (ATC). Keith C. Bible, M.D., Ph.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues reviewed the relevant literature to develop guidelines relating to the

Better treatment for aggressive prostate cancer

New research from CU Cancer Center member Scott Cramer, Ph.D., and his colleagues could help in the treatment of men with certain aggressive types of prostate cancer. Published this week in the journal Molecular Cancer Research, Cramer’s study specifically looks at how the loss of two specific prostate tumor-suppressing genes—MAP3K7 and CHD1 —increases androgen receptor